Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  AstraZeneca    AZN   GB0009895292

ASTRAZENECA

(AZN)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 2016 2017 2018 2019 (e) 2020 (e) 2021 (e)
Sales 23 002 22 465 22 090 23 691 26 090 28 595
EBITDA 7 259 6 713 7 140 6 871 8 161 9 852
Operating profit (EBIT) 6 721 6 855 5 672 6 340 7 371 8 915
Pre-Tax Profit (EBT) 3 552 2 227 1 993 3 079 4 342 6 066
Net income 3 499 3 001 2 155 2 415 3 476 4 830
P/E ratio 19,8x 29,2x 44,0x 42,3x 31,5x 23,0x
EPS ( $ ) 2,76 2,37 1,70 1,88 2,52 3,46
Dividend per Share ( $ ) 2,80 2,80 2,80 2,81 2,85 2,92
Yield 5,11% 4,05% 3,74% 3,53% 3,58% 3,66%
Reference price ( $ ) 54,785 69,123 74,881 79,571 79,571 79,571
Announcement Date 02/02/2017
07:00am
02/02/2018
07:00am
02/14/2019
07:00am
- - -
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 2016 2017 2018 2019 (e) 2020 (e) 2021 (e)
Debt 10 657 14 483 14 282 10 897 10 453 9 390
Finance - - - - - -
Operating income (EBITDA) 7 259 6 713 7 140 6 871 8 161 9 852
Leverage
(Debt/EBITDA)
1,47x 2,16x 2,00x 1,59x 1,28x 0,95x
Capital Expenditure 1 446 1 326 1 043 1 212 1 223 1 319
Book Value Per Share (BVPS) ( $ ) 11,7 11,8 9,84 11,8 11,2 12,7
Cash Flow per Share ( $ ) 3,27 2,82 2,07 3,18 4,88 6,17
Announcement Date 02/02/2017
07:00am
02/02/2018
07:00am
02/14/2019
07:00am
- - -
Balance Sheet Analysis
Assessed data source
© 2019 S&P Global Market Intelligence
Financial Ratios

Size 2019e 2020e
Capitalization 104 380 M $ -
Entreprise Value (EV) 115 276 M $ 114 833 M $
Valuation 2019e 2020e
P/E ratio (Price / EPS) 42,3x 31,5x
Capitalization / Revenue 4,41x 4,00x
EV / Revenue 4,87x 4,42x
EV / EBITDA 16,8x 14,1x
Yield (DPS / Price) 3,53% 3,58%
Price to book (Price / BVPS) 6,73x 7,09x
Profitability 2019e 2020e
Operating Margin (EBIT / Sales) 26,8% 28,3%
Operating Leverage (Delta EBIT / Delta Sales) 1,62x 1,61x
Net Margin (Net Profit / Revenue) 10,2% 13,3%
ROA (Net Profit / Asset) 4,34% 6,25%
ROE (Net Profit / Equities) 26,4% 32,5%
Rate of Dividend 149% 113%
Balance Sheet Analysis 2019e 2020e
CAPEX / Sales   5,11% 4,69%
Cash Flow / Sales 17,6% 24,5%
Capital Intensity (Assets / Sales) 2,35x 2,13x
Financial Leverage (Net Debt / EBITDA) 1,59x 1,28x
EPS & Dividend